Patterson Cos. (PDCO) came out with quarterly earnings of $0.47 per share, missing the Zacks Consensus Estimate of $0.49 per share.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Patterson Cos. (PDCO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2024.
PDCO's fiscal second-quarter results are likely to reveal a decline in both the Dental and Animal Health segments, reflecting challenges like moderating traffic to clinics.
Investors remain optimistic about Patterson Companies on the back of its broad product line.
PDCO's latest agreement with PDS Health to extend their deal is likely to streamline operations, optimize efficiency and maximize profitability.
Investors remain optimistic about Patterson Companies on the back of its broad product line.
Patterson Companies announces to invest in two separate businesses to boost its animal health business.
Patterson Cos. (PDCO) reported earnings 30 days ago.
Investors remain optimistic about Patterson Companies on the back of its broad product line.
Patterson Companies announced disappointing fiscal 2025 Q1 results. A cyberattack on Change Healthcare affected Patterson more than expected.
Patterson Companies, Inc. (NASDAQ:PDCO ) Q1 2025 Earnings Conference Call August 28, 2024 8:30 AM ET Company Participants John Wright - Vice President, Investor Relations Don Zurbay - President and Chief Executive Officer Kevin Barry - Chief Financial Officer Conference Call Participants Jonathan Block - Stifel Brandon Vazquez - William Blair Allen Lutz - Bank of America Jeffrey Johnson - Robert W. Baird Elizabeth Anderson - Evercore ISI Jason Bednar - Piper Sandler Michael Cherny - Leerink Partners Erin Wright - Morgan Stanley Operator Good morning and welcome to the Patterson Companies, Inc. First Quarter Fiscal 2025 Earnings Call.
Patterson Companies' first-quarter fiscal 2025 results reflect the negative impact of a cyberattack on its vendor, Change Healthcare.